- Home
- APLT vs AAME Comparison
APLT vs AAME Comparison
Compare APLT & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AAME
- Stock Information
- Founded
- APLT 2016
- AAME 1968
- Country
- APLT United States
- AAME United States
- Employees
- APLT N/A
- AAME N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AAME Life Insurance
- Sector
- APLT Health Care
- AAME Finance
- Exchange
- APLT Nasdaq
- AAME Nasdaq
- Market Cap
- APLT 63.6M
- AAME 68.4M
- IPO Year
- APLT 2019
- AAME N/A
- Fundamental
- Price
- APLT $0.41
- AAME $3.44
- Analyst Decision
- APLT Buy
- AAME
- Analyst Count
- APLT 6
- AAME 0
- Target Price
- APLT $6.10
- AAME N/A
- AVG Volume (30 Days)
- APLT 771.9K
- AAME 38.7K
- Earning Date
- APLT 11-06-2025
- AAME 11-11-2025
- Dividend Yield
- APLT N/A
- AAME 0.59%
- EPS Growth
- APLT N/A
- AAME N/A
- EPS
- APLT N/A
- AAME 0.10
- Revenue
- APLT $121,000.00
- AAME $198,977,000.00
- Revenue This Year
- APLT N/A
- AAME N/A
- Revenue Next Year
- APLT $5,931.24
- AAME N/A
- P/E Ratio
- APLT N/A
- AAME $32.42
- Revenue Growth
- APLT N/A
- AAME 6.98
- 52 Week Low
- APLT $0.30
- AAME $1.25
- 52 Week High
- APLT $10.62
- AAME $3.71
- Technical
- Relative Strength Index (RSI)
- APLT 38.50
- AAME 66.93
- Support Level
- APLT $0.40
- AAME $3.20
- Resistance Level
- APLT $0.46
- AAME $3.35
- Average True Range (ATR)
- APLT 0.03
- AAME 0.20
- MACD
- APLT -0.01
- AAME -0.03
- Stochastic Oscillator
- APLT 7.74
- AAME 86.67
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.